Skip to main content
. Author manuscript; available in PMC: 2023 Apr 20.
Published in final edited form as: Acc Mater Res. 2022 Mar 4;3(3):283–296. doi: 10.1021/accountsmr.1c00178

Figure 7.

Figure 7.

(A) Synthesis of the cisplatin prodrug containing an additional drug moiety, (B) physical entrapment of two drugs in a nanodelivery vehicle, (C) incorporation of a fixed ratio of the cisplatin prodrug and other agents into single polymer for spatiotemporal controlled release, and (D) polymeric nanoparticles with ability to deliver drugs such as cisplatin, chlorambucil, or aspirin to the mitochondria of cisplatin-resistant cancer cells.